MetLife, Inc. (NYSE:MET) Shares Acquired by Parkside Financial Bank & Trust

Parkside Financial Bank & Trust lifted its position in shares of MetLife, Inc. (NYSE:METFree Report) by 10.4% during the fourth quarter, Holdings Channel.com reports. The firm owned 2,799 shares of the financial services provider’s stock after acquiring an additional 263 shares during the period. Parkside Financial Bank & Trust’s holdings in MetLife were worth $185,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Wedge Capital Management L L P NC grew its stake in shares of MetLife by 3.8% during the 4th quarter. Wedge Capital Management L L P NC now owns 572,751 shares of the financial services provider’s stock worth $37,876,000 after purchasing an additional 21,063 shares during the period. RWA Wealth Partners LLC grew its stake in shares of MetLife by 29.9% during the 4th quarter. RWA Wealth Partners LLC now owns 7,138 shares of the financial services provider’s stock worth $472,000 after purchasing an additional 1,642 shares during the period. Duality Advisers LP acquired a new stake in shares of MetLife during the 4th quarter worth approximately $3,797,000. Commerzbank Aktiengesellschaft FI grew its stake in shares of MetLife by 39.4% during the 4th quarter. Commerzbank Aktiengesellschaft FI now owns 29,672 shares of the financial services provider’s stock worth $1,963,000 after purchasing an additional 8,393 shares during the period. Finally, Cetera Trust Company N.A purchased a new position in shares of MetLife during the 4th quarter valued at approximately $2,126,000. Institutional investors and hedge funds own 89.81% of the company’s stock.

Analyst Ratings Changes

MET has been the topic of a number of recent analyst reports. UBS Group decreased their target price on MetLife from $87.00 to $82.00 and set a “buy” rating on the stock in a research report on Monday, February 5th. Wells Fargo & Company increased their target price on MetLife from $83.00 to $86.00 and gave the company an “overweight” rating in a research report on Thursday, April 11th. Piper Sandler increased their target price on MetLife from $74.00 to $85.00 and gave the company an “overweight” rating in a research report on Friday, April 5th. Keefe, Bruyette & Woods increased their target price on MetLife from $82.00 to $87.00 and gave the company an “outperform” rating in a research report on Wednesday, April 10th. Finally, Morgan Stanley increased their target price on MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a research report on Monday, April 15th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, MetLife currently has an average rating of “Moderate Buy” and an average price target of $79.23.

Get Our Latest Research Report on MetLife

Insider Buying and Selling

In other MetLife news, insider Ramy Tadros sold 4,026 shares of MetLife stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the transaction, the insider now directly owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, EVP Bill Pappas sold 27,000 shares of MetLife stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $72.27, for a total value of $1,951,290.00. Following the completion of the transaction, the executive vice president now owns 57,768 shares in the company, valued at approximately $4,174,893.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total value of $289,469.40. Following the sale, the insider now owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The disclosure for this sale can be found here. Corporate insiders own 0.32% of the company’s stock.

MetLife Trading Up 0.7 %

Shares of MET stock opened at $72.72 on Thursday. MetLife, Inc. has a fifty-two week low of $48.95 and a fifty-two week high of $74.68. The firm has a market capitalization of $52.58 billion, a P/E ratio of 39.74, a PEG ratio of 0.54 and a beta of 1.04. The stock’s fifty day moving average is $71.36 and its two-hundred day moving average is $67.06. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.16 and a current ratio of 0.16.

MetLife (NYSE:METGet Free Report) last issued its earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.02). MetLife had a return on equity of 19.48% and a net margin of 2.36%. The company had revenue of $18.72 billion during the quarter, compared to analyst estimates of $18.07 billion. Research analysts expect that MetLife, Inc. will post 8.71 earnings per share for the current fiscal year.

MetLife Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 11th. Investors of record on Tuesday, May 7th will be given a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a dividend yield of 3.00%. This is an increase from MetLife’s previous quarterly dividend of $0.52. The ex-dividend date is Monday, May 6th. MetLife’s dividend payout ratio (DPR) is presently 113.66%.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.